TickrTrends HQY fair value analysis

HQY Maintained by BMO Capital -- Price Target Raised to $125

gurufocus.com · 2026-10-21

HealthEquity (HQY) Analyst Rating Update On October 03, 2023, BMO Capital maintained an Outperform rating on HealthEquity (HQY), raising the price target fro

TickrTrends take: BMO Capital's maintenance of coverage with a raised price target to $125 suggests analyst confidence in HQY's fundamentals within the Healthcare sector. Given TickrTrends' current assessment of the stock as undervalued, this price target elevation provides a data point for valuation-focused readers to monitor against the company's actual trading price and near-term financial performance. Investors tracking the gap between the new analyst target and the stock's market price may gain insight into how the market is pricing in the company's growth prospects relative to the analyst's view.

Read the full story at gurufocus.com →

Is HQY undervalued? See TickrTrends' fair value analysis →